TYPE: Prescription

BRAND: Fesoterodine Rowa

ACTIVE INGREDIENT: Fesoterodine

 

STRENGTH, PACK SIZE & GMS CODE:

Fesoterodine Rowa 4mg prolonged-release tablets x 28 (66826)
Fesoterodine Rowa 8mg prolonged-release tablets x 28 (66827)

 

INDICATION:

Therapeutic indications:

Adults for treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur with overactive bladder syndrome.

 

Fesoterodine Rowa 4mg prolonged-release tablets SPC and Patient Information Leaflet

Fesoterodine Rowa 8mg prolonged-release tablets SPC and Patient Information Leaflet